Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Issue navigator


 


Contents of Volume 5 Suppl 2
1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease
Meeting abstracts
Kühtai, Austria. 25 April 2003
Edited by S Assaad-Khalil, H Direskeneli, M Schirmer
This workshop was supported in part by Merck Austria and the Scientific Society of Hematology, Oncology and Immunology, Innsbruck Austria

Meeting abstract    
Introduction
CG Barnes
Arthritis Res Ther 2003, 5(Suppl 2):1 (9 September 2003)
[Full text] [PDF] [PubMed] [Related articles]

Meeting abstract    
Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
S Assaad-Khalil
Arthritis Res Ther 2003, 5(Suppl 2):2 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Cytotoxic drugs in ocular lesions of Behçet's disease
F Davatchi, F Shahram, H Chams, A Nadji, AR Jamshidi, C Chams, M Akbarian, F Gharibdoost, M Sedigh, B Sadeghi
Arthritis Res Ther 2003, 5(Suppl 2):3 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
The use of interferon-alfa in Behçet's disease: review of the literature
I Kötter, I Günaydin, M Zierhut, N Stübiger
Arthritis Res Ther 2003, 5(Suppl 2):4 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial
I Kötter, M Treusch, R Vonthein, M Zierhut, A Eckstein, T Ness, I Günaydin, B Grimbacher, S Blaschke, HH Peter, N Stübiger
Arthritis Res Ther 2003, 5(Suppl 2):5 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
TNF and anti-TNF agents in Behçet's disease
KT Calamia
Arthritis Res Ther 2003, 5(Suppl 2):6 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
A review on disease activity scores in Behçet's disease (BD)
M Baltaci
Arthritis Res Ther 2003, 5(Suppl 2):7 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Behçet's disease: from innate to adaptive immunity
H Direskeneli
Arthritis Res Ther 2003, 5(Suppl 2):8 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Migration of dendritic cells into the lymphatics: the Langerhans cell example
N Romani, P Stoitzner, S Ebner, H Stössel, S Holzmann, G Ratzinger, P Fritsch
Arthritis Res Ther 2003, 5(Suppl 2):9 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease
EU Irschick, HP Huemer, C Larcher, R Sgonc, W Göttinger
Arthritis Res Ther 2003, 5(Suppl 2):10 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Regulation of inflammatory CD28- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?
C Duftner, C Goldberger, E Märker-Hermann, M Schirmer
Arthritis Res Ther 2003, 5(Suppl 2):11 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model
S Sohn, M Lutz, HJ Kwon, G Konwalinka, S Lee, M Schirmer
Arthritis Res Ther 2003, 5(Suppl 2):12 (9 September 2003)
[Full text] [PDF]

Meeting abstract    
Streptococcal antigen in the pathogenesis of Behçet's disease
F Kaneko, H Yanagihori, M Tojo, E Isogai, SN Lin, K Oguma
Arthritis Res Ther 2003, 5(Suppl 2):13 (9 September 2003)
[Full text] [PDF]

edit my details
Arthritis Research & Therapy
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central



© 1999-2008 BioMed Central Ltd unless otherwise stated < info@arthritis-research.com >   Terms and conditions